Works by Arzt, Jennifer

Results: 4
    1
    2

    Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: Outcome and Minimal Residual Disease (MRD) from the Full Population of the Pivotal M13-982 Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S303, doi. 10.1016/j.clml.2017.07.098
    By:
    • Wierda, William;
    • Chyla, Brenda;
    • Eichhorst, Barbara;
    • Schetelig, Johannes;
    • Munir, Talha;
    • Hillmen, Peter;
    • Seymour, John F.;
    • Roberts, Andrew W.;
    • Coutre, Steven;
    • Jurczak, Wojciech;
    • Mulligan, Stephen P.;
    • Wendtner, Clemens-Martin;
    • Davids, Matthew;
    • Böettcher, Sebastian;
    • Cerri, Elisa;
    • Zhou, Lang;
    • Popovic, Relja;
    • Poteracki, Mia;
    • Arzt, Jennifer;
    • Kim, Su Young
    Publication type:
    Article
    3
    4